Published in AIDS Weekly, March 24th, 2003
"Increased drug levels could overcome resistance and improve the response to a salvage regimen," argued researchers in Spain.
J. L. Casado and colleagues at Hospital Ramon y Caja evaluated "the inhibitory quotient (IQ, C-trough/protein-binding corrected IC50) as a predictor of virological response in 52 patients included in two dual protease inhibitor (PI)-based salvage regimens."
"The HIV-RNA level decrease at 12 weeks was greater in patients who achieved an IQ greater than 1," their report indicated.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.